APOA2 and metabolic syndrome: A study investigating the impact of weight loss on HDL apoAII kinetics in the metabolic syndrome reported a significant correlation between changes in apoAII fractional catabolic rate and visceral adipose tissue mass, indicating a potential role for adiposity in the regulation of apoAII catabolism [23].